|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 双氢青蒿素哌喹复方治疗无并发症恶性疟的临床观察显示文摘 | 宋建平 Duong Socheat Suou Seila Thou Tharith SesS arim Sim Yutheasa 谈博 李国桥 | 2003 | 中华医学杂志2003，83，12： | 9 |
| 2 | 青蒿素哌喹片治疗间日疟62例临床报道显示文摘【目的】观察青蒿素哌喹片(Artequick)治疗间日疟的有效性、安全性及临床剂量。【方法】对62例间日疟患者采用成人总量4片Artequick 2 d疗程的给药方案治疗,观察近期治愈率、近期复发率以及平均原虫复燃天数等有效性指标,并评价其安全性。【结果】62例患者经治疗后临床症状较快缓解,平均原虫转阴时间为(60.7±23.9)h,平均退热时间为(14.1±7.8)h,其中54例完成28 d观察,近期治愈率为94.4%(51/54例),近期复发率为5.6%(3/54例)。本组病例对Artequick的耐受性良好,仅有少数病人出现恶心、呕吐;且为自限性;比较服药前与服药后第7天的血液、生化、心电图等指标,未发现Artequick片有明显的毒性。【结论】青蒿素哌喹片治疗间日疟,具有高效、速效、副反应少等优点,值得临床推广应用。 | 邓长生 谈博 DUONG Socheat SUOU Seila 徐颖 欧凤珍 SRENG Sokunthea LEAP Sophorn NGET Nom 宋健平 | 2008 | 广州中医药大学学报2008，25，3： | 5 |
| 3 | 青蒿素哌喹片治疗无并发症恶性疟的剂量探索试验显示文摘目的探索青蒿素哌喹片治疗无并发症恶性疟的安全有效的适宜剂量。方法收治7~65岁男性和女性病人共100例,按区组随机化方案分成2组,成人总量1400 mg组年龄(22±s12)岁,1750 mg组年龄(21±12)岁。分别于0h和24h给药一次,比较2组的平均原虫转阴和退热时间、28d治愈率及原虫复燃率。结果2组的平均原虫转阴时间分别是(61±19)h和(57±21)h,平均退热时间为(20±15)h和(18±10)h,P>0.05;28 d治愈率是80%和96%,原虫复燃率为20%和4%,总量1750 mg组显著优于1400 mg组(P<0.05)。2组耐受性均良好,未发现明显的不良反应。结论推荐青蒿素哌喹片的临床治疗剂量为总量1750 mg,每日1次,分2d服完为1个疗程。 | 宋健平 谈博 DUONG Socheat SUOU Seila 徐颖 欧凤珍 SRENG Sokunthea LEAP Sophorn 李国桥 | 2008 | 中国新药与临床杂志2008，27，12： | 2 |
| 4 | Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C:a pilot study显示文摘 | Suou T Mitsuda A Koda M | 2001 | Hepatol Res2001，20，3： | 1 |
| 5 | Changes in serum tissue inhibitor of matrix metdloproteinase-1 after interferon alpha treatment in chronic hepatitis C显示文摘 | Mitsuda A Suou T Ikuta Y | 2000 | J Hepatol2000，32，4： | 1 |
| 6 | Hepatotoxicity of cyelophosphamide in man:pharmacokinetic analysis显示文摘 | Honjo I Suou T Hirayama C | 1988 | Res Commun Chen Pathol Pharmaclo1988，61，2： | 1 |
| 7 | Circulating p53 Antibody in Patients with Colorectal Cancer显示文摘 | Goshi Shiota Masato Ishida Naoya Noguchi Kenji Oyama Yuji Takano Michiko Okubo Shunsuke Katayama Yasushi Tomie Kenichi Harada Kotaro Hori Kumiyo Ashida Yosuke Kishimoto Akihide Hosoda Takeaki Suou Takamasa Kanbe Kiwamu Tanaka Kimiyasu Nosaka Osamu Tanida | 2000 | Digestive Diseases and Sciences2000，，1： | 1 |
| 8 | Changes in serum tissue inhibitor of matrix metdloproteinase-1 after interferon alpha treatment in chronic hepatitis C 显示文摘 | Akeri Mitsuda Takeaki Suou Yujiro Ikuta | 2000 | Journal of Hepatology2000，32，： | 1 |
| 9 | Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies显示文摘 | Kawatani T Suou T Tajima F | 2001 | Eur J Haematol2001，67，： | 1 |
| 10 | Hepatotoxieity of cyclophosphamide in mana: pharmacokinetic analysis 显示文摘 | HONJO I SUOU T HIRAYAMA C | 1998 | Res Commun Chen Pathol Pharmaclo1998，61，2： | 1 |
| 11 | Changes in serum tissue inhibitor of matrix metalloproteinase-1 after interferon alpha treatment in chronic hepatitis C 显示文摘 | Mitsuda A Suou T Ikuta Y | 2000 | J Hepatol2000，32，4： | 1 |
| 12 | Apigenin inhibitstumor necrosis factor a-induced cell proliferation andprostaglandin E2 synthesis by inactivating NFkB inendometriotic stromal cells 显示文摘 | Suou K Taniguchi F Tagashira Y | 2011 | Fertil Steril2011，95，4： | 1 |
| 13 | Hepatotoxicity of cyclophosphamide in man:pharmacokinetic analysis显示文摘 | Honjo I Suou T Hirayama C | 1988 | Res Commun Chem Pathol Pharmacol1988，61，： | 1 |
| 14 | Changes in serum tissue inhibitor of matrix metalloproteinase-1 after int-erferon alpha treatment in chronic hepatitis C显示文摘 | Suou T Ikuta Y | 2000 | J He-patol2000，32，4： | 1 |
| 15 | Serum and urinary neopterin levers in patients with chronic active hepatitis B treated with interferon显示文摘 | Daito K Suou T Kawasaki H | 1994 | Res Comun Chem Pathol Pharmacol1994，83，： | 1 |
| 16 | Hepatotoxicity of cyclophosphamide in mana: pharmacokinetic analysis 显示文摘 | Honjo I Suou T Hirayama C | 1998 | Res Commun Chen Pathol Pharmaclo1998，61，2： | 1 |
| 17 | Change in serum tissue inhibitor of matrix metalloproteinase-l after interferon alpha treatment in chronic hepatitis C显示文摘 | MITSUDA A SUOU T ILUTA Y | 2000 | J Hepatol2000，32，66： | 1 |
| 18 | Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia显示文摘 | Kiyomi Ishiga Toshio Kawatani Takeaki Suou Fumihito Tajima Hiromi Omura Youko Idobe Hironaka Kawasaki | 2001 | International Journal of Hematology2001，，1： | 1 |
| 19 | Serum and urinary neopterin levers in patients with chronic active hepatitis B treated with interferon显示文摘 | Daito K Suou T Kawasaki H | 1994 | Res Comun Chem Pathol Pharmacol1994，8，3： | 1 |
| 20 | Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma显示文摘 | Yosuke Kishimoto Tsuyoshi Morisawa Masayuki Kitano Goshi Shiota Yasushi Horie Takeaki Suou Hisao Ito Hironaka Kawasaki Junichi Hasegawa | 2001 | Hepatology Research2001，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员